Category: Surgical Endoscopy

Endoscopic ultrasonography-guided ethanol injections demonstrate efficacy for small pancreatic tumors

A prospective multicenter study evaluated endoscopic ultrasonography-guided ethanol injections (EUS-EI) for treating small pancreatic neuroendocrine neoplasms (PNENs). Of the 25 patients treated, 76% achieved the primary endpoint compared to surgical outcomes, and 88% attained complete ablation at 1 and 6 months. Safety results were promising, with 96% experiencing no severe adverse events within one month. […]

Better IPMN risk stratification could optimize cancer surgery decisions.

Personalized Cancer Risk Thresholds Can Guide IPMN Surgery Decisions Clinicians found that optimal cancer risk thresholds (CRT) for surgery in patients with branch-duct intraductal papillary mucinous neoplasms (bd-IPMN) vary based on age, comorbidities, and tumor location. For a 60-year-old with mild comorbidities, surgery was favored at a 20% CRT for tumors in the pancreatic head […]

Small-sized capsule gastroscopy effectively screens gastrointestinal diseases

A retrospective analysis involving 2,163 asymptomatic individuals revealed that small-sized magnetically controlled capsule gastroscopy (mccg) successfully detected gastrointestinal issues such as submucosal tumors (1.57%), polyps (15.16%), and ulcers (1.25%). Detection rates for polyps were notably higher in females and increased with age. The procedure was well-tolerated, with no significant discomfort or adverse events reported, demonstrating […]

Prophylactic closure of mucosal defects lowers adverse event risks

Prophylactic closure of mucosal defects significantly reduces delayed bleeding and perforation risks following endoscopic resection, according to a systematic review and meta-analysis of 28 studies involving 11,383 patients. The closure group exhibited a 60% lower risk for delayed bleeding compared to non-closure (risk ratio: 0.40), although no significant reduction in postpolypectomy coagulation syndrome (PPCS) was […]

Double-balloon platform significantly reduces colorectal ESD procedure time

A randomized controlled trial demonstrated that the double-balloon interventional platform (DBIP) markedly reduced mean procedure time for colorectal endoscopic submucosal dissection (ESD) to 88.6 minutes, compared to 139.5 minutes for traditional ESD—a 36.5% reduction. Additionally, DBIP-assisted ESD improved en-bloc resection rates and sutured defect closures while saving $610.16 per patient, indicating its effectiveness and cost […]

Endoscopic submucosal dissection is pivotal for early gastric cancer treatment

Endoscopic submucosal dissection (ESD) is crucial for early gastric cancer (EGC) management, often necessitating additional gastrectomy in cases deemed non-curative. Analysis of 134 patients revealed key factors such as deep submucosal invasion and positive margins that led to further surgical intervention. Notably, independent risk factors for lymph node metastasis included positive vertical margin and lymphatic […]

Combination of hepaticogastrostomy and stenting enhances outcomes

A systematic review assessed the effectiveness of hepaticogastrostomy with antegrade stenting (hgas) compared to hepaticogastrostomy alone (hgs) for malignant biliary obstruction. Findings revealed pooled clinical success rates of 94% for hgas versus 88% for hgs, while re-intervention needs were significantly lower with hgas (OR=0.37). Although overall adverse events were similar, hgas led to reduced bile […]

EUS-guided gastroenterostomy shows promise over traditional methods

EUS-guided gastroenterostomy has gained recognition as an effective alternative to surgical gastrojejunostomy and duodenal stenting for treating gastric outlet obstruction. Key advantages include reduced invasiveness, shorter hospital stays, and potentially improved patient outcomes. This comprehensive review highlights the evolved techniques and their comparative effectiveness, affirming that EUS-guided gastroenterostomy offers significant benefits without the need for […]

Per-Oral Endoscopic Myotomy (POEM) Offers Critical Guidelines

A clinical practice update presented vital guidance on per-oral endoscopic myotomy (POEM), emphasizing that extensive diagnostic evaluations are essential before treatment. It highlights POEM as the preferred option for type III achalasia, while also supporting laparoscopic Heller myotomy and pneumatic dilation for other types. Antibiotic prophylaxis, post-procedure monitoring for gastroesophageal reflux disease, and individualized discharge […]

Sigmoid-type achalasia shows higher risk of esophageal cancer

In a study involving 450 achalasia patients undergoing peroral endoscopic myotomy (POEM), treatment outcomes were favorable across disease types, with efficacy rates of 97.9% and 94.2% at one and two years, respectively. However, the incidence of esophageal cancer varied significantly among types: 1% in straight, 2.5% in sigmoid type 1, and 10% in sigmoid type […]